Oral diseases · 2025
Molecular Markers of Tumor Invasion in Ameloblastoma: A Systematic Review.
СтатьяСистематический обзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Escobar-Duarte Bárbara, Hidalgo-Valenzuela Javiera, Marín Márquez Constanza
Аннотация
BACKGROUND: Ameloblastoma is a benign odontogenic tumor characterized by local aggressiveness and high recurrence rates.
AIM: To identify and classify molecular biomarkers associated with its invasive behavior.
METHODS: Following PRISMA recommendations for Systematic Reviews, a comprehensive search was conducted in PubMed, Scopus, Web of Science, and gray literature for English-language studies published between March 2020 and March 2025. Eligible studies included those using human tissues, retrospective case series, or in vitro assays with experimental validation. Studies focused solely on clinical, radiological, or histopathological aspects were excluded. Risk of bias was assessed using the Joanna Briggs Institute checklist for case series and the QUIN tool for in vitro studies. Data extraction was carried out independently by three reviewers.
RESULTS: A total of 34 studies met the inclusion criteria, identifying 70 biomarkers related to tumor invasion. These were categorized by biological function, with the most commonly reported involved in extracellular matrix degradation, epithelial-mesenchymal transition, bone remodeling, cell proliferation, stemness, and the tumor microenvironment.
CONCLUSIONS: The findings suggest that metalloproteinases, cytokines, and EMT-related proteins are key drivers of invasion. These biomarkers may represent valuable therapeutic targets for developing innovative and less invasive treatment strategies. This review was registered in the Open Science Framework.
AIM: To identify and classify molecular biomarkers associated with its invasive behavior.
METHODS: Following PRISMA recommendations for Systematic Reviews, a comprehensive search was conducted in PubMed, Scopus, Web of Science, and gray literature for English-language studies published between March 2020 and March 2025. Eligible studies included those using human tissues, retrospective case series, or in vitro assays with experimental validation. Studies focused solely on clinical, radiological, or histopathological aspects were excluded. Risk of bias was assessed using the Joanna Briggs Institute checklist for case series and the QUIN tool for in vitro studies. Data extraction was carried out independently by three reviewers.
RESULTS: A total of 34 studies met the inclusion criteria, identifying 70 biomarkers related to tumor invasion. These were categorized by biological function, with the most commonly reported involved in extracellular matrix degradation, epithelial-mesenchymal transition, bone remodeling, cell proliferation, stemness, and the tumor microenvironment.
CONCLUSIONS: The findings suggest that metalloproteinases, cytokines, and EMT-related proteins are key drivers of invasion. These biomarkers may represent valuable therapeutic targets for developing innovative and less invasive treatment strategies. This review was registered in the Open Science Framework.